High-dose liraglutide improves metabolic syndrome in poor responders to bariatric surgery

Abstract

In patients who experience poor response after BS, liraglutide is well tolerated and promotes significant weight loss, ameliorates cardiometabolic comorbidities, and reduces the prevalence of MS.